연구동향 분석

Reports : Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress

( Pyung Hwan Kim ) ( Sang Su Na ) ( Bomnaerin Lee ) ( Joo Hyun Kim ) ( Je Yoel Cho ) 2015년

논문상세정보
인용/피인용
' Reports : Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • mesenchymal stem cells
  • oxidative stress
  • stanniocalcin- 2
  • stem cell-based therapy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
561 0

0.0%

' Reports : Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress' 의 참고문헌

  • mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10to sites of inflammation
    Levy O Blood 122 : 23 ~ 32 [2013]
  • The stanniocalcin family of proteins
    Wagner GF J Exp Zool A Comp Exp Biol 305 : 769 ~ 780 [2006]
  • The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma
    Sheppard KE Clin Cancer Res 19 : 5320 ~ 5328 [2013]
  • Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies
    Mimeault M Clin Pharmacol Ther 82 : 252 ~ 264 [2007]
  • Stanniocalcin-1 protects retinal ganglion cells by inhibiting apoptosis and oxidative damage
    Kim SJ PLoS One 8 : e63749 ~ [2013]
  • Stanniocalcin-1 protects bovine intestinal epithelial cells from oxidative stress-induced damage
    Wu LM J Vet Sci 15 : 475 ~ 483 [2014]
  • Stanniocalcin 2is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer
    Bouras T Cancer Res 62 : 1289 ~ 1295 [2002]
  • Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis
    Wu S J Biol Chem 281 : 5120 ~ 5127 [2006]
  • STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro
    Haixiao Wang BMB Reports 45 (11) : 629 ~ 634 [2012]
  • Redox homeostasis: the linchpin in stem cell self-renewal and differentiation
    Wang K Cell Death Dis 4 : e537 ~ [2013]
  • Preconditioning stem cells for in vivo delivery
    Sart S Biores Open Access 3 : 137 ~ 149 [2014]
  • Oct4and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells
    Tsai CC Mol Cell 47 : 169 ~ 182 [2012]
  • Neural stem cells genetically modified to overexpress cu/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice
    Sakata H Stroke 43 : 2423 ~ 2429 [2012]
  • Mesenchymal stromal cells: current understanding and clinical status
    Salem HK Stem Cells 28 : 585 ~ 596 [2010]
  • Mesenchymal stromal cells: Tissue repair and immune modulation
    Le Blanc K Cytotherapy 8 : 559 ~ 561 [2006]
  • Mammalian stanniocalcins and cancer
    Chang AC Endocr Relat Cancer 10 : 359 ~ 373 [2003]
  • Mammalian cell-cycle regulation:several Cdks, numerous cyclins and diverse compensatory mechanisms
    Satyanarayana A Oncogene 28 : 2925 ~ 2939 [2009]
  • Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress
    Bahmani B Cell Stress Chaperones 19 : 685 ~ 693 [2014]
  • Ischemic preconditioning for cell-based therapy and tissue engineering
    Hsiao ST Pharmacol Ther 142 : 141 ~ 153 [2014]
  • Injectable multifunctional microgel encapsulating outgrowth endothelial cells and growth factors for enhanced neovascularization
    Kim PH J Control Release 187 : 1 ~ 13 [2014]
  • Immunogenicity of pluripotent stem cells and their derivatives
    de Almeida PE Circ Res 112 : 549 ~ 561 [2013]
  • Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling
    Westberg JA Stroke 38 : 1025 ~ 1030 [2007]
  • Hydrogel matrix to support stem cell survival after brain transplantation in stroke
    Zhong J Neurorehabil Neural Repair 24 : 636 ~ 644 [2010]
  • Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy
    Estrada JC Cell Death Dis 4 : e691 ~ [2013]
  • Human adipose-derived mesenchymal stem cells in vitro: evaluation of an optimal expansion medium preserving stemness
    Baer PC Cytotherapy 12 : 96 ~ 106 [2010]
  • HIF-2alpha suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells
    Das B Stem Cells 30 : 1685 ~ 1695 [2012]
  • Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression
    Okabe H Cancer Res 61 : 2129 ~ 2137 [2001]
  • Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities
    Go MJ Exp Cell Res 314 : 1147 ~ 1154 [2008]
  • Evolution and roles of stanniocalcin
    Yeung BH Mol Cell Endocrinol 349 : 272 ~ 280 [2012]
  • Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin-mediated toxicity
    Liu TC J Tissue Eng Regen Med 7 : 302 ~ 311 [2013]
  • Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis
    Romanov VS Biochemistry (Mosc) 77 : 575 ~ 584 [2012]
  • Clinical significance of STC1 gene expression in patients with colorectal cancer
    Tamura S Anticancer Res 31 : 325 ~ 329 [2011]
  • Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells
    Sotiropoulou PA Stem Cells 24 : 462 ~ 471 [2006]
  • Cdk2 : a key regulator of the senescence control function of Myc
    Hydbring P Aging (Albany NY) 2 : 244 ~ 250 [2010]
  • CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
    Gogolin S Cell Cycle 12 : 1091 ~ 1104 [2013]
  • Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers
    Fujiwara Y Int J Oncol 16 : 799 ~ 804 [2000]
  • Aging of mesenchymal stem cell in vitro
    Bonab MM BMC Cell Biol 7 : 14 ~ [2006]
  • A review of bioreactor protocols for human neural precursor cell expansion in preparation for clinical trials
    Baghbaderani BA Curr Stem Cell Res Ther 6 : 229 ~ 254 [2011]